New York's Eleven Madison Park has been announced as the best restaurant in the world during an award ceremony held in Melbourne on Wednesday night.
This is the first win for Eleven Madison Park, an upscale US restaurant housed in an art deco building with high ceilings overlooking New York's Madison Square Park.
The restaurant, which was voted number three last year, is most famous for its multi-course seasonal tasting menu celebrating the city's rich history and culinary traditions, the organiser, William Reed Business Media, said.
It was also voted the best restaurant in North America in 2017.
The awards, in their 15th year, are created from the votes of The World's 50 Best Restaurants Academy, which is made up of more than 1,000 influential food writers, critics, chefs and restaurateurs.
"The restaurant's co-owners, Will Guidara and Swiss-born chef Daniel Humm, enhance the fine-dining experience with a sense of fun, blurring the line between the kitchen and the dining room," the academy said in a statement.
The list features various cuisines from different cultures and includes restaurants from 22 countries across five continents.
"All 50 restaurants represent the very best culinary experiences and talent," William Drew, one of the organisers, said in a statement.
Last year's top restaurant, Osteria Francescana in Modena of Italy, claimed the second position, while retaining its title of the best restaurant in Europe.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
Trump derides doctors as Covid surges, Biden says Trump 'giving up' on virus
US reports world record of more than 100,000 Covid-19 cases in single day
As final weekend looms, Trump and Biden to barnstorm across Midwest
Warning of ‘unrelenting’ Covid-19 spread issued
Trump and Biden home in on Florida for votes
Teacher turns Kingston walls into blackboards
59 bodies found in clandestine graves in Mexico's Guanajuato state
Trump, Biden battle for Florida on same day as race nears end
US strikes deal with Lilly for potential Covid-19 antibody drug